On February 20, 2024 ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, reported that company management will participate in the upcoming February conferences (Press release, ReCode Therapeutics, FEB 20, 2024, View Source;utm_medium=rss&utm_campaign=recode-therapeutics-to-participate-in-february-conferences [SID1234640289]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

William Blair Private Company Focus Conference
Format: Fireside Chat
Date: February 22, 2024
Time: 12:00 p.m. ET
Location: Virtual

Evercore ISI 2024 Emerging Biotech Conference
Format: Company Presentation
Date: February 28, 2024
Time: 4:00 p.m. ET
Location: Virtual